The DOI matches its Crossref record; 82 of the 89 references it cites were found in a registry or an index; 31 of the 64 sources its claims cite were checked for support.
Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review
Open accessAbstract
The co-occurrence of substance use disorders (SUDs) and psychiatric conditions, often referred to as comorbidity or concurrent disorders, presents intricate challenges in both diagnosis and treatment. This comprehensive narrative review aims to synthesize and critically evaluate the existing evidence surrounding the management of individuals with comorbid SUDs and psychiatric disorders. Comorbidity in these domains carries profound implications for clinical practice, research, and policymaking, emphasizing the need for a holistic understanding of the intricate dynamics that arise when these conditions coexist. This review explores recent research findings, evidence-based guidelines, and emerging trends within the field, offering valuable insights for clinicians, researchers, and policymakers seeking to navigate the complex terrain of comorbidity in substance use and psychiatric disorders. © 2024 by the author.
Overview
CoChat Summary
TL;DR
This is a narrative review of how to manage co-occurring substance use disorders (SUDs) and psychiatric disorders, emphasizing that diagnosis and treatment are complicated by overlapping symptoms, self-medication, and social factors. The paper argues that integrated, individualized, and holistic care is preferred over serial care, while noting that evidence for some pharmacologic and psychotherapeutic strategies remains limited or mixed.
Key findings
- Dual diagnosis is common and clinically consequential: in a US study using National Epidemiologic Survey on Alcohol and Related Conditions Wave III data, adults with dual diagnoses accounted for 26% of those with psychiatric disorders, 37% of those with SUDs, and 18% of the total 76 million adults with either condition.
- Among children/adolescents in a systematic review, dual-diagnosis prevalence ranged from 18% to 54%, with an average prevalence of 33%; males were more likely to experience dual diagnoses, and affective disorders were the most prevalent psychiatric diagnoses.
- Integrated care is presented as the favored treatment model: studies cited in the paper found it improves treatment engagement, substance use, mental health, and overall quality of life.
- Psychosocial treatments and some medications show promise, but evidence is uneven: meta-reviews found psychosocial treatments produce small to moderate benefits versus inactive controls in the short term, and clozapine has been associated with higher odds of abstinence and reduced psychiatric hospitalization, though the paper says evidence remains inconclusive due to limited samples and incomplete reporting in randomized trials.
Methods
- This is a comprehensive narrative review synthesizing existing evidence, recent research findings, evidence-based guidelines, and emerging trends on comorbid SUDs and psychiatric disorders.
- The paper draws on prior reviews, meta-analyses, systematic reviews, guidelines, and selected studies across topics including integrated care, pharmacologic treatment, psychotherapy, harm reduction, alcohol use disorder with mood/anxiety disorders, and stimulant use disorder with ADHD.
- No new dataset, sample, or primary statistical analysis was conducted; the paper is a literature synthesis.
Limitations
- The paper states that evidence for several interventions is limited, mixed, or inconclusive, including pharmacological treatments in general, clozapine because of limited sample sizes and insufficient reporting in randomized controlled trials, and prescription stimulants for stimulant use disorder.
- It also notes that harm reduction’s impact on people with comorbid conditions remains less well-defined, and that more research is needed to assess interventions tailored to this population.
- Evident from the text: because this is a narrative review, it does not present a systematic search strategy, formal quality assessment, or pooled effect estimates (not stated in the paper).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
18 Valid · 1 Not valid · 14 Not checked · 4 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“the prevalence of dual diagnoses within this specific target population ranged from 18% to 54%, with an average prevalence of 33%.”
§ Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review > 2. Prevalence and Characteristics of Dual Diagnoses
What the sources say
- Supportedcites [9] Tomáš, J., and Lenka, Š. (2023). Prevalence of Dual Diagnoses among Children and Adolescents with Mental Health Conditions. Children, 10. source
Section 3.1 reports that prevalence among children and adolescents treated primarily for mental health conditions ranged from 18.3% to 54%, with a mean of 32.7%. The citing sentence rounds these figures to 18%–54% and 33%. The same section cautions that study sample sizes differed and the rates are not strictly comparable. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“current evidence strongly supports an approach known as integrated care.”
§ Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review > 4. The Role of Integrated Care
What the sources say
- Not checked — no full text of the sourcecites [12] Crockford, 2021, Current Challenges With Comorbid Psychiatric and Substance Use Disorders, Can. J. Addict. source
- Partly supportedcites [14] George, 2022, Why Integrating Medications and Psychosocial Interventions Is Important to Successfully Address the Opioid Crisis in Canada, Can. J. Psychiatry sourceExperimental — accuracy not yet measured
“Putting it All Together” advocates integrated mental health, addiction, and medical care for people with opioid use disorder (OUD). But the paper addresses OUD specifically, rather than comorbid substance use disorders and psychiatric conditions generally. “The Importance of Integrating PSIs into the Treatment of OUD” also says evidence for combining psychosocial interventions with opioid agonist treatment is mixed, so “strongly supports” overstates that evidence. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“psychosocial treatments yield small to moderate benefits compared to inactive controls in the short-term [39,40,41,42,43,44].”
§ Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review > 6. Psychotherapeutic Approaches
What the sources say
- Not checked — no full text of the sourcecites [39] Dellazizzo, 2023, Meta-Review on the Efficacy of Psychological Therapies for the Treatment of Substance Use Disorders, Psychiatry Res. source
- Partly supportedcites [40] Subodh, 2018, Psychosocial Interventions in Patients with Dual Diagnosis, Indian J. Psychiatry sourceExperimental — accuracy not yet measured
The Introduction reports narrow benefits from adding psychosocial interventions to usual medical treatment in patients with dual diagnosis. It does not quantify those benefits as small to moderate or establish a short-term advantage over inactive controls. The section on psychotic disorders and substance use disorders instead describes the comparative evidence as insufficient. (LLM, conf=0.82)
- Partly supportedcites [41] Barbui, 2020, Efficacy of Psychosocial Interventions for Mental Health Outcomes in Low-Income and Middle-Income Countries: An Umbrella Review, Lancet Psychiatry sourceExperimental — accuracy not yet measured
The Description of included systematic reviews (page unavailable) reports comparisons of psychosocial interventions with inactive controls, but its list of studied populations does not include substance use disorders. The Discussion (page unavailable) reports benefits for several other mental health conditions and says long-term effectiveness was seldom assessed. It does not establish small-to-moderate short-term benefits for SUDs. (LLM, conf=0.83)
- Partly supportedcites [42] Volkow, 2020, Personalizing the Treatment of Substance Use Disorders, Am. J. Psychiatry sourceExperimental — accuracy not yet measured
In “Treating the Dimensions of Substance Use Disorder” (page not specified), the paper says cognitive-behavioral treatments and contingency management have benefits for specific aspects of addiction. It does not quantify those benefits as small to moderate or compare them with inactive controls over the short term. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [43] Lappan, 2020, Dropout Rates of In-Person Psychosocial Substance Use Disorder Treatments: A Systematic Review and Meta-Analysis, Addiction source
- Not checked — no full text of the sourcecites [44] Marienfeld, C. (2020). Absolute Addiction Psychiatry Review: An Essential Board Exam Study Guide, Springer International Publishing. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Left untreated, MDD among individuals with AUD can have profound consequences [65].”
§ Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review > 8. Addressing Comorbidity in Alcohol Use Disorders and Anxiety/Depression
What the sources say
- Partly supportedcites [65] Samet, 2013, Effects of Independent and Substance-Induced Major Depressive Disorder on Remission and Relapse of Alcohol, Cocaine and Heroin Dependence, Addiction sourceExperimental — accuracy not yet measured
The Discussion reports that MDD increased relapse risk among patients with alcohol dependence, supporting the claim that it can have serious consequences. But the study did not establish those consequences specifically for untreated MDD: it controlled for treatment and did not analyze depression-treatment status in detail. No page numbers are available in our copy. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Evidence-based strategies, including contingency management (CM), cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing (MI), acceptance and commitment therapy (ACT), and family-based interventions, have demonstrated their effectiveness in reducing substance use and enhancing treatment outcomes”
§ Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review > 6. Psychotherapeutic Approaches
What the sources say
- Not checked — no full text of the sourcecites [45] Dom, G., and Moggi, F. (2015). Co-Occurring Addictive and Psychiatric Disorders: A Practice-Based Handbook from a European Perspective, Springer. source
- Not checked — no full text of the sourcecites [46] Lee, 2015, A Systematic Review of Interventions for Co-Occurring Substance Use and Borderline Personality Disorders, Drug Alcohol Rev. source
- Partly supportedcites [47] Harada, T., Tsutomi, H., Mori, R., and Wilson, D.B. (2018). Cognitive-behavioural Treatment for Amphetamine-type Stimulants (ATS)-use Disorders. Cochrane Database Syst. Rev. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [48] Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., and Fairbairn, N. (2020). Treatment of Stimulant Use Disorder: A Systematic Review of Reviews. PLoS ONE, 15. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [49] Magill, 2019, A Meta-Analysis of Cognitive-Behavioral Therapy for Alcohol or Other Drug Use Disorders: Treatment Efficacy by Contrast Condition, J. Consult. Clin. Psychol. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [50] Ray, 2020, Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-Analysis, JAMA Netw. Open sourceExperimental — accuracy not yet measured
The Introduction calls CBT a first-line treatment for alcohol and other substance use disorders, and the Results report reduced substance-use frequency and quantity for CBT plus pharmacotherapy versus usual care plus pharmacotherapy. The Discussion also describes contingency management and other behavioral treatments as having empirical support. The paper does not establish effectiveness for the full list in the claim: the passages found do not assess dialectical behavior therapy, acceptance and commitment therapy, or family-based interventions. (LLM, conf=0.88)
- Not matchedcites [51] Haktanir, 2020, Meta-Analysis of Dialectical Behavior Therapy (DBT) for Treating Substance Use, Res. Educ. Psychol.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [52] Hakobyan, S., Vazirian, S., Lee-Cheong, S., Krausz, M., Honer, W.G., and Schutz, C.G. (2020). Concurrent Disorder Management Guidelines. Systematic Review. J. Clin. Med., 9. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that integrated care for people with concurrent disorders reduced substance use and improved mental health compared with standard care. It does not establish those outcomes for the six named strategies individually; searches for their names found no such findings in our copy. (LLM, conf=0.84)
- Partly supportedcites [53] Orchowski, 2021, A Review of Research-Supported Group Treatments for Drug Use Disorders, Subst. Abuse Treat. Prev. Policy sourceExperimental — accuracy not yet measured
The Conclusions (page unavailable) report reduced substance use or improved outcomes for CBT, CM, and brief motivational interviewing in specific drug-use settings. The review also reports benefit from DBT for people with co-occurring substance use disorder and borderline personality disorder. The Method section describes family therapy but does not establish its effectiveness, and no passage found addresses acceptance and commitment therapy; the claim therefore overstates what this review supports. (LLM, conf=0.88)
- Partly supportedcites [54] Magill, 2023, Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate?, Subst. Abuse Rehabil. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports that CBT is generally more effective than usual community care and that CBT combined with motivational interviewing or contingency management is efficacious. The Introduction names dialectical behavior therapy and acceptance and commitment therapy as related approaches, but does not establish their effectiveness for substance use; the paper also does not establish effectiveness for family-based interventions. The claim therefore extends beyond the evidence this source reports. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims · 9 with their cited sources checked
Create a free account to see all 37 claims and every source verdict.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 10
Citations
Cites
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693
Cognitive Behavioral Therapy for Substance Use Disorders
McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.012 · Cited by 626 · cited 1×
“…(DBT), motivational interviewing (MI), acceptance and commitment therapy (ACT), and family-based interventions, have demonstrated their effectiveness in reducing substance use and enhancing treatment outcomes by addressing the psychological, behavioral, and social aspects of addiction [45–56].”
BackgroundCo-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Brady, K. T., & Sinha, R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1483 · Cited by 552
Treatment engagement of individuals experiencing mental illness: review and update
Dixon, L. B., Holoshitz, Y., & Nossel, I. (2016) · World Psychiatry · doi:10.1002/wps.20306 · Cited by 550 · cited 1×
“By leveraging the potential benefits of pharmacological interventions within a broader treatment framework, we can optimize outcomes for individuals with dual diagnoses [32,33].”
BackgroundAlcoholics Anonymous and other 12-step programs for alcohol use disorder
Kelly, J. F., Humphreys, K., & Ferri, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012880.pub2 · Cited by 462 · cited 1×
“The effectiveness of 12-step group facilitation interventions, such as Alcoholics Anonymous (AA), in addressing SUDs, particularly alcohol use disorder (AUD), is supported by high-quality evidence [57], showing their efficacy in promoting abstinence.”
BackgroundDrake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2004.360.374 · Cited by 459
Motivational interviewing for substance abuse
Smedslund, G., Berg, R. C., Hammerstrøm, K. T., Steiro, A., Leiknes, K. A., Dahl, H. M., & Karlsen, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008063.pub2 · Cited by 408
Cited by
Deep, P. D., Ghosh, N., Gaither, C., & Rahaman, M. S. (2024) · Psychoactives · doi:10.3390/psychoactives3040028 · Cited by 32
“Bahji notes that the intricate interplay between the psychological, biological, and social underpinnings of these dual conditions characterizes the co-occurrence of SUDs and psychiatric conditions [34].”
InfluentialChiappini, S., Gramuglia, P. D., Mosca, A., Cavallotto, C., Miuli, A., Corkery, J., Guirguis, A., Schifano, F., & Martinotti, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1508732 · Cited by 29
Cavallotto, C., Chiappini, S., Mosca, A., d’Andrea, G., Carlo, F. D., Piro, T., Susini, O., Stefanelli, G., Cesare, A. D., Ricci, V., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082206 · Cited by 23
“Several reviews and meta-analyses consistently indicate a significantly higher prevalence of comorbidity in comparison to the general population [5].”
BackgroundMüller, V., Mellor, D., & Pikó, B. F. (2024) · Learning Disabilities Research & Practice · doi:10.1177/09388982241271511 · Cited by 13
“It is important to acknowledge that self-reported ADHD symptoms can overlap with other conditions, including substance use disorders (Bahji, 2024), autism spectrum disorder (Waldren et al., 2024), learning disabilities (Kellens et al., 2024), bipolar disorder (Barden et al., 2023), mood disorders…”
Concurrent Disorders and Treatment Outcomes: A Meta-Analysis
Scott, K. D., & Gorey, K. M. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2515015 · Cited by 17
“The need for treatment integration seems clear, yet institutions seem to remain staunchly siloed, keeping addiction treatment separate from other mental health treatments (Bahji, 2024; Hakobyan et al., 2020; Wiktorowicz et al., 2019).”
Metadata
- Authors
- Bahji, A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Bahji, Anees
- ORCID
- Bahji, Anees
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-02-09
- Volume
- 13
- Issue
- 4
- Pages
- 999
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC10889170
- OpenAlex
- W4391692641
- Semantic Scholar
- 467002ddef1d8c68e4493bbe190bc32d2b192f36
- Cited by
- 83
- References
- 89
- Citations by year
- 2026: 48 · 2025: 26 · 2024: 9
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R25DA037756)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- substance use disorders, mental illness, comorbidities, concurrent disorders, diagnosis, treatment, evidence-based recommendations, clinical practice, mental health policy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review. https://app.cochat.ai/papers/10.3390/jcm13040999
- The paper
- Bahji, A. (2024). Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13040999
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.